Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibody Responses to Reduced Dose Menomune in Children Previously Vaccinated with TetraMenD
NCT00772070Phase 2Completed
- Sponsor
- Sanofi
- Start
- Mar 2003
- Primary completion
- Aug 2003
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label trial of quadrivalent meningococcal polysaccharide vaccine in meningococcal infection (2 arms), sponsored by Sanofi. Primary endpoint: Geometric Mean Titers of Serum Bactericidal Activity at Day 28. Started Mar 2003; status: completed.
02
Drugs
quadrivalent meningococcal polysaccharide vaccine
03
Conditions
meningococcal infection
Beyond the preview
Go deeper on NCT00772070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00772070.